# Study of ONO-1078 in Patients With Chronic Sinusitis

> **NCT00410735** · PHASE3 · COMPLETED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 495 (actual)

## Conditions studied

- Chronic Sinusitis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Pranlukast hydrate

## Key facts

- **NCT ID:** NCT00410735
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-06
- **Final completion:** —
- **Target enrollment:** 495 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410735, "Study of ONO-1078 in Patients With Chronic Sinusitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00410735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*